|
|
||||||||
Department of Medicine, University of California, San Diego, La Jolla, California 92093-0623
| |
ABSTRACT |
|---|
|
|
|---|
It has been proposed that, in skeletal muscle,
the angiogenic response to exercise may be signaled by the increase in
muscle blood flow, via biomechanical changes in the microcirculation (increased shear stress and/or wall tension). To
examine this hypothesis, we compared the change in abundance of
vascular endothelial growth factor (VEGF), basic fibroblast growth
factor (bFGF), and transforming growth
factor-
1
(TGF-
1) mRNA in skeletal
muscles of the canine leg after 1 h of pump-controlled high blood flow alone (passive hyperperfusion; protocol
A) and electrical stimulation of the femoral and
sciatic nerves producing muscle contraction (protocol
B). The increase in leg blood flow (5.4- and 5.9-fold change from resting values, respectively) was similar in both groups.
Passive hyperperfusion alone did not increase message abundance for
VEGF (ratio of mRNA to 18S signals after vs. before hyperperfusion,
0.94 ± 0.08) or bFGF (1.08 ± 0.05) but slightly increased that
of TGF-
1 (1.14 ± 0.07;
P < 0.03). In contrast, as
previously found in the rat, electrical stimulation provoked more than
a threefold increase in VEGF mRNA abundance (3.40 ± 1.45;
P < 0.02). However, electrical
stimulation produced no significant changes in either bFGF (1.16 ± 0.13) or TGF-
1 (1.31 ± 0.27). These results suggest that the increased muscle blood flow of exercise does not account for the increased abundance of these angiogenic growth factor mRNA levels in response to acute
exercise. We speculate that other factors, such as local
hypoxia, metabolite concentration changes, or mechanical effects of
contraction per se, may be responsible for the effects of exercise.
vascular endothelial growth factor; basic fibroblast growth factor; transforming growth factor; Northern analysis
| |
INTRODUCTION |
|---|
|
|
|---|
FORMATION OF NEW CAPILLARIES and thus the increase in
the number of capillaries per muscle fiber occur under physiological circumstances during endurance training as part of the adaptive responses of the cardiovascular and skeletal muscle systems to improve
O2 transfer to myocytes (4, 5, 8).
Angiogenesis can be considered as the culmination of several steps
involving dissolution of the extracellular matrix underlying the
endothelium, cell migration, and endothelial cell proliferation (21,
24). A number of naturally occurring growth factors and cytokines can induce and/or promote formation of new vessels by stimulating endothelial cell growth and migration. Growth factors known to be
involved in such processes include vascular endothelial growth factor
(VEGF) (27), basic fibroblast growth factor (bFGF) (17), and
transforming growth factor-
1
(TGF-
1) (31), as well as several cytokines (34, 38).
It has been recently shown in intact rats (7, 19) that exercise induces
greater expression of genes encoding angiogenic growth factors. Our
laboratory demonstrated by quantitative Northern blot analyses (7) that
the mRNA levels for VEGF in gastrocnemius muscle rose substantially
immediately after a single bout of exercise in the untrained intact
rat. The response was quantitatively related to exercise intensity and
was augmented by hypoxia. The bFGF and TGF-
1 mRNA levels increased
less with exercise, and hypoxia had no effect at all on bFGF message.
Similarly, Hang et al. (19) demonstrated a significant increase of VEGF
mRNA levels in anterior tibialis and extensor digitorum longus muscles
in rats after electrical stimulation for up to 21 days. Interestingly,
these authors (19) found higher VEGF mRNA levels in the early stages of
muscle stimulation and gradually decreasing levels at later stages.
Many unanswered questions remain regarding the stimuli and underlying mechanisms that modulate transcription of angiogenic growth factors. It has been hypothesized that different biomechanical changes in the microcirculation linked with exercise, namely 1) shear stress within the vessels (21), 2) increased capillary wall tension (21, 22), and, 3) stretching of capillaries due to mechanical distortion (21, 22), may play a significant role in the upregulation of angiogenic growth factors. It is well accepted that increased blood flow increases the velocity of flow in capillaries (40) and thus calculated shear stress within vessels (11, 20). A competing hypothesis (1) is that increased metabolic requirements of the tissue cells is the primary factor leading to angiogenesis. In this hypothesis, O2 has been implicated as a major control element, because vessel growth increases during hypoxic conditions (1, 34, 39) and decreases during hyperoxic conditions. Intracellular PO2 falls to very low levels (3 Torr) in normal human muscle during exercise (37).
In the present investigation, a canine preparation was used to
determine whether acute passive hyperperfusion of one leg, presumably
via biomechanical changes in the microcirculation, induces a
significant increase in mRNA abundance for VEGF, bFGF, and
TGF-
1. The study was designed
to compare the effects of passive hyperperfusion alone on angiogenic
growth factor mRNA responses vs. those provoked by contraction-induced
hyperperfusion. In both instances, changes in gene expression of the
test leg were compared with those of the corresponding resting muscle
groups of the contralateral leg, which served as controls, pump
perfused at intact resting blood flow rates.
| |
METHODS |
|---|
|
|
|---|
This study was approved by the University of California, San Diego, Animal Subjects Committee. Ten adult mongrel dogs of either sex, weighing 17.7 ± 1.8 kg, were initially studied, but three of them were excluded from the study due to technical problems reported in Experimental protocol. The animals were anesthetized with 30 mg/kg of pentobarbital sodium, and maintenance doses were given as required. The dogs were intubated with an endotracheal tube, the cuff of which could be inflated to ensure a tight seal. Heating pads were used to maintain esophageal temperature at 37°C. Ventilation with room air was maintained by using a tidal volume of ~15 ml/kg at a respiratory rate required to preserve normal values of arterial PO2 and PCO2 throughout the study with the use of a Harvard 613 ventilator. End-expired O2 and CO2 and airway pressure were monitored during the study. Positive end-expiratory pressure of ~5 cmH2O was applied throughout the study. The animals were given heparin at a dosage of 1,500 U/kg after surgical preparation.
Dog preparation. One carotid artery was cannulated to monitor systemic blood pressure and for arterial blood sampling. The proximal portion of the femoral artery just below the inguinal ligament of both legs (test leg and control leg) was exposed over a length of ~7 cm, and resting blood flow was measured (see Experimental protocol). The two ends of a single, heparinized, saline-filled length of plastic tubing were introduced into the femoral artery proximally and distally, respectively. During the surgical procedure, special care was taken to prevent ties of collateral branches of the femoral artery that might perturb blood flow to the skeletal muscles in the hindlimb of the dog. The outflow from the proximal end of the femoral artery was passed through this tubing via a roller pump (Sigmamotor, Cole-Palmer Instrument, Chicago, IL) for controlled perfusion to the distal portion of the femoral artery. A pressure transducer in the distal part of the arterial line constantly monitored perfusion pressure. An electromagnetic flow probe (T106-3RB, Transonic Systems, Ithaca, NY) was placed distally to the pump around the femoral artery to monitor blood flow in the test leg throughout the study. In those animals in which electrical stimulation was performed (protocol B), after initial measurements of resting blood flow of both legs, the femoral and sciatic nerves of the test leg were doubly ligated and cut between ties.
Experimental protocol. Protocol A (passive hyperperfusion) initially included five dogs, but data from two of them could not be used. Dog 1 was excluded before any molecular analysis was performed, because the quality of the surgical procedure and maintenance of the animal preparation during the study were considered suboptimal (hypovolemic shock), and dog 4 could not be used because of mRNA degradation in all muscle biopsies taken. Thus only the three remaining dogs (dogs 2, 3, and 5) are reported in this protocol. A total of 18 individual muscles, representing 10 different muscle groups from the 3 dogs, was sampled, and mRNA levels were measured.
Resting blood flow in both femoral arteries was recorded by using the flow probes, and functional preservation of both femoral arteries was checked by the increase in flow provoked by the endothelium-dependent reactive vasodilation after the release of an acute compression of the artery. In the femoral artery of the test leg, the pump was set to provide flow at resting levels for a short period. Then the perfusion pressure was increased slowly in steps of ~25 mmHg until a "plateau" in both pressure and flow was achieved at each step. This procedure was repeated up to a rate four- to sixfold higher than resting levels, provided that arterial pressure did not exceed 200 mmHg. High flow was maintained for 1 h. Protocol B (electrical stimulation) initially included five dogs, but one of them (dog 6) could not be used because of technical problems in the preparation (ischemia in the control leg due to an inadvertent surgical procedure error). Consequently, only data from dogs 7, 8, 9, and 10 are reported in the protocol. A total of 10 actively contracting muscles was sampled from these four dogs. The initial steps of the experimental procedure were identical in both protocols except for the fact that femoral and sciatic nerves of the test leg were cut after measurement of resting blood flow. During the 1-h treatment, four periods of isometric muscle contractions (tetanic) were elicited by stimulation of the femoral and sciatic nerves with square-wave impulses (8 V) of 0.2-ms duration for 200 ms (50 Hz) at a rate of 1 contraction/s for a 3-min work period. Twelve minutes were allowed between contraction periods for recovery. Perfusion pressure of the test leg was maintained at 200 mmHg during the 1-h period by adjusting blood flow via the roller pump. In both protocols (passive hyperperfusion and electrical stimulation), at the end of the 1-h high blood flow treatment, perfusion pressures reproducing resting blood flow conditions were temporarily set, and blood flow was measured by using a graduated cylinder to calibrate the flow probe. This was repeated in the test leg at high blood flow conditions. Immediately thereafter, with the animal under deep anesthesia, the skin of both legs was removed, and muscle biopsies (1-1.5 g each) were taken from the following muscle groups from the test and contralateral legs: 1) sartorius, 2) rectus femoris, 3) vastus medialis, 4) gracilis, 5) vastus lateralis, 6) gastrocnemius, 7) tibial cranial, 8) semimembranosus, 9) biceps femoris, and 10) semitendinosus. In dogs 7 and 10 (both being early in the experimental series), only one muscle group (gastrocnemius) in both legs was stimulated and thus biopsied. Finally, animals were euthanized with an overdose of pentobarbital sodium.mRNA isolation and Northern analysis.
Total cellular RNA was isolated from each muscle sample by the method
of Chomczynski and Sacchi (10). RNA preparations were quantitated by
absorbance at 260 nm, and intactness was assessed by ethidium bromide
staining. Ten micrograms of total cellular RNA were separated by
electrophoresis in 6.6% formaldehyde-1% agarose gel. Fractionated RNA
was transferred by Northern blot to a Zeta probe membrane (Bio-Rad,
Hercules, CA). RNA was cross-linked to the membrane by ultraviolet
irradiation by using an ultraviolet cross-linker (model FD-UVXL 1000, Fisher Scientific) and stored at 4°C. The blots were then probed
with oligolabeled
[
-32P]deoxycytidine
triphosphate cDNA probes, which had a specific activity of
1 × 109
disintegrations · min
1 · µg
DNA
1 (13). The human VEGF
probe is a 0.93-kb cDNA fragment isolated from the EcoR I
site of pUC-derived plasmid (27). The human TGF-
1 cDNA probe is a 0.985-kb
Hind III/Xba I insert
cloned into pBluescript II KS+
vector (36). The bFGF probe is a 1-kb
Xho I fragment of human bFGF cDNA
(24). Prehybridization and hybridizations were performed in 50%
formamide, 5× SSC (20× SSC is 0.3 M sodium chloride and 0.3 M sodium citrate), 10× Denhardt's solution (100×
Denhardt's solution is 2% Ficoll and 2% polyvinyl pyrrolidone), 50 mM sodium phosphate (pH 6.5), 1% SDS, and 250 µg/ml of sonicated
salmon sperm DNA at 37 or 42°C. Blots were washed with 2× SSC
and 0.1% SDS at room temperature, with 0.1× SSC and 0.1%
SDS at 55°C for the VEGF mRNA, and with 1× SSC
and 0.1% SDS at 60°C for
TGF-
1 and bFGF mRNAs. Blots
were exposed to XAR-5 X-ray film (Eastman Kodak, New Haven, CT) by use
of a Cronex Lightning Plus screen at
70°C. In all analyses,
quantitative densitometry of the autoradiographs was used to measure
the mRNA levels for all three growth factors. Each blot was
subsequently reprobed (after prior complexes were stripped) with a cDNA
specific for 18S ribosomal RNA, and this signal was used to normalize
the mRNA signal for minor variations in the lane loading. Because
acceptable reproducibility of the technique in our hands has been
previously demonstrated (7), duplicate analyses were not performed on
the samples.
Statistical treatment. For the three growth factors, results were examined as the ratio of 18S-normalized mRNA levels in the test leg compared with those observed in the same muscle of the contralateral (control) leg of each animal, such that lack of effect of any experimental condition would give rise to a ratio of 1.0. This analysis was independently performed for the two different protocols: protocol A, passive hyperperfusion only (3 dogs, n = 18 samples); and protocol B, muscle contraction by electrical stimulation (4 dogs, n = 10 samples). In each protocol (passive hyperperfusion and contraction-induced hyperperfusion), 12 muscle samples were not considered in the analyses because of mRNA degradation in either the experimental or the control leg. The results represent an average of the effects of each experimental condition in all individual muscles sampled. The null hypothesis was tested for each condition by using Student's paired t-test comparing the ratio to 1.0. Comparisons between groups of animals were done by using an unpaired analysis. Statistical significance was accepted if P < 0.05. Results are expressed as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
In protocol A (passive
hyperperfusion), blood flow in the test leg was 5.4 ± 0.87-fold
(range 3.8-6.8) higher than under control conditions. No
statistically significant differences were observed in blood flow
measured during electrical stimulation [5.9 ± 0.60-fold (range 4.7-6.5)]. Although the relative increases in flow
were not different between the two protocols, it is possible that
differences in vascular resistance could have exposed the muscle
microvasculature to different hemodynamic conditions, which could then
be argued to explain the VEGF mRNA results despite similar increases in flow per se. To examine this possibility, the increase in flow divided
by the increase in perfusion pressure (from rest to high-flow state)
was computed for each dog and compared. These ratios were not
significantly different (P = 0.4) at
2.7 l · min
1 · mmHg
1
in the passively perfused group and 3.5 l · min
1 · mmHg
1
in the electrically stimulated muscles group, suggesting that the
microvascular beds of the two groups were reflecting similar hemodynamic conditions. Averaged for all dogs, absolute values for
resting and high blood flows in the test leg were 58 ± 7.3 and 320 ± 37.6 ml/min, respectively.
Apparently negative results always require special effort to minimize the possibility that a type II (false negative) error has occurred. Consequently, we reanalyzed the data 1) without the 18S RNA normalization, because in some cases the densitometer may have been reading beyond its linear range, and 2) by nonparametric tests (Wilcoxon's signed rank test). The outcome in both cases was the same as originally seen: passive hyperperfusion did not alter VEGF mRNA, whereas electrically stimulated contraction did.
Figures 1 and 2 show the
Northern blots from protocol A (high
blood flow by passive hyperperfusion). It is clear that VEGF (Fig.
1) and bFGF mRNA levels (Fig. 2)
did not show significant changes immediately after high blood flow for
1 h. As shown in the figure,
TGF-
1 slightly but
significantly increased. Figures 3 and
4 portray the Northern blots in
protocol B (similar high flow during
electrical stimulation of the femoral and sciatic nerves). An increase
in the abundance of VEGF mRNA (Fig. 3) can be seen in
the contracting muscle groups (gastrocnemius, sartorius, vastus
medialis, rectus femoris, and vastus lateralis) indicated in the
figure, but significant changes were not observed in bFGF or
TGF-
1 (Fig.
4).
|
|
|
|
Figure 5 portrays the quantitative
densitometry (mRNA levels normalized by 18S ribosomal RNA) for the
three growth factors: VEGF, bFGF, and
TGF-
1. Results
(y-axes) are expressed as the high flow-to-rest
flow ratio for each experimental condition. In the three panels, the
left bar indicates the change in mRNA expression during passive hyperperfusion alone
(protocol A), and the
right bar corresponds to the signal
obtained at similar high-flow levels in the electrically stimulated
muscles (protocol B). As indicated
above, we observed no significant increase in the mRNA expression of
two of the growth factors (VEGF and bFGF) during passive
hyperperfusion: however, TGF-
1
was only slightly elevated (14%; P < 0.03). In contrast, more than a threefold increase in VEGF mRNA
abundance (P < 0.02) was observed
after electrical stimulation. There were no significant changes in both
bFGF and TGF-
1 mRNA levels in
this experimental condition.
|
| |
DISCUSSION |
|---|
|
|
|---|
The study by Breen et al. (7) showed that mRNA levels of angiogenic
growth factors (VEGF, bFGF, and
TGF-
1) in rat gastrocnemius increased significantly after 1 h of normoxic exercise in the intact
animals. The response was quantitatively related to the exercise
intensity and was augmented when the rats were exercised while
breathing a low inspired O2
concentration of 0.12. These results (7), as well as those reported by
Hang et al. (19) using electrical stimulation, show that muscle
activity leads to an early increase of mRNA levels for angiogenic
growth factors. Local hypoxia (1, 34, 39) and several other stimuli,
some of them potentially related to inadequate tissue cell oxygenation, such as changes in local pH, release of microvascular vasodilators, or
modifications of local concentrations of metabolites, may be postulated
as triggers of angiogenesis induced by exercise.
A competing hypothesis is that biomechanical events at the level of the microcirculation (shear stress within vessels, capillary wall tension, or vascular stretch; Refs. 21, 22) may play a significant role in exercise-induced angiogenesis. Growth of new vessels induced after long-term administration of different types of vasodilators (21) has been attributed to biomechanical effects of increased blood flow through increase in shear stress and/or capillary wall tension. It has been shown that local release of polypeptides that modulate smooth muscle growth is signaled by changes in the shape of endothelial cells (15, 23), from a spheroid to a flat configuration, and also by the reduction of the contacts between adjacent endothelial cells (9, 26). The angiogenic role of biomechanical forces (20, 33) is substantially reinforced by the observation that capillary sprouts in chronically stimulated skeletal muscle are found predominantly at sites of maximum curvature of preexisting capillaries.
However, the main finding in the present study is that passive
hyperperfusion (5.4-fold increase in blood flow alone) maintained for 1 h did not produce significant changes in mRNA levels for VEGF and bFGF.
The change in TGF-
1, while
statistically significant, was relatively small. In contrast, a similar
increase in blood flow occurring during electrical stimulation provoked
a more than threefold increase in VEGF mRNA levels (Fig.
5). These results therefore suggest that, if
biomechanical changes in the skeletal muscle microcirculation occur
with fivefold increases in blood flow induced by exercise, they do not
play a significant role in the mRNA abundance of angiogenic growth
factors. In contrast, short-term increases in metabolic
muscle requirements, provoked by short-term exercise in intact animals
(7) and during short- (present study) or long-term electrical
stimulation (19), induce a significant mRNA response of angiogenic
growth factors, mainly for VEGF. It must be pointed out, however, that
the present study does not address whether increased VEGF mRNA
abundance represents increased transcription and/or increased
message stability within the myocyte.
A potential limitation of the present study is that the lack of change
in the average mRNA responses of angiogenic growth factors after
passive hyperperfusion (Fig. 1) could reflect the balance between
muscles that were highly perfused and increased in mRNA VEGF levels and
those that were less well perfused through nonuniform flow distribution
such that mRNA levels went down. We argue that such a possibility was
ruled out by the uniformity of the response to high blood flow over all
18 muscles (Figs. 1 and 2). The low variance in the response to passive
hyperperfusion is illustrated by the low standard errors of the mRNA
ratios for VEGF, bFGF, and
TGF-
1 depicted in Fig. 5,
left bars. Moreover, as total femoral
flow was passively increased over fivefold, it is hard to imagine that,
in any muscle, flow under these conditions could be less than when
femoral flow was at fivefold lower resting levels.
After electrical stimulation (Fig. 5,
right bars), the dissociation between
the increase in VEGF mRNA levels and the lack of changes in mRNA levels
for bFGF and TGF-
1 is not
unexpected. The study by Breen et al. (7) also showed a higher signal
for VEGF than for bFGF and
TGF-
1. In addition, the four
3-min electrical stimulation periods may not produce the same effects
as natural exercise for 1 h, and one must also remember that the data
of Breen et al. were for another species (rat). We should take into account that the results may also be related to the time of sampling relative to the onset of the stimulus (7, 39). Possibly, passive
hyperperfusion could affect growth factor mRNA levels, but we failed to
see this because of our sampling protocol, i.e., taking the muscle for
analysis at a single time point within minutes of the end of
contractions or hyperperfusion. However, because the earlier work from
our laboratory showed immediate increases in mRNA signals (7) that were
reproduced in the contracting muscles from the present study, we would
argue that, even if we missed seeing some delayed response, any such
response would not reflect the exercise-induced response of the intact
muscle that we were attempting to explain in the first place.
VEGF, also called vascular permeability factor, is actually a family of
several highly specific, potent growth factors inducing endothelial
mitogenesis (25, 35). The key importance of VEGF in
initial vascular development is emphasized by the fact that removal of
the VEGF gene is lethal early in embryogenesis in animals heterozygous
for gene mutation (14) and that VEGF inactivation reduces angiogenesis
in tumors (6, 41) and in the eye (2, 3). Upregulation of VEGF gene
expression may represent an early response to increased metabolic
requirements that corresponds with the short half-time of VEGF mRNA
levels determined in vascular smooth muscle cells (29). bFGF is also a
direct angiogenic factor; however, it has a broader cell-type
specificity. It has been suggested that bFGF may represent a more
long-term response to muscle stimulation (31).
TGF-
1 is an indirect angiogenic
factor with a wide variety of effects on cell proliferation and
regulation of extracellular matrix components.
The dissociation between the response of VEGF to electrical stimulation
and the lack of signal in both bFGF and
TGF-
1 may also suggest
differences in promoter regions in the genes of these angiogenic growth
factors. Whereas hypoxic regulatory sequences in both the 5' and
3' regulatory regions of the VEGF gene (16, 28, 30) have been
clearly demonstrated, this is not the case for bFGF and
TGF-
1. It is also possible that
TGF-
1 and bFGF are activated by
release of mediators from the cell or extracellular matrix (12, 32) and
not stimulated at the transcriptional level. Furthermore, both bFGF and
TGF-
1 seem to be involved in the regulation of VEGF, resulting in a network of growth factor interactions. Although the above interpretation is still partly speculative, the dissociation of the VEGF mRNA response to electrical stimulation provides a rationale for further search of the regulatory regions in the genes of these angiogenic growth factors. Recently, Gu
and Adair (18) showed that hypoxia can induce the expression of VEGF
mRNA and its protein in cultured dog myocardial vascular smooth muscle
cells, suggesting that vascular smooth muscle cells might also play an
angiogenic role in the regulation of the expression of VEGF.
In summary, the present study demonstrates that 1 h of passive
hyperperfusion alone does not induce increases in mRNA levels for VEGF
or bFGF but does induce minimal increases (14%) in those for
TGF-
1. In contrast, VEGF mRNA
levels show a marked enhancement after muscle contraction at similar
high blood flow. Our results support the hypothesis that early
exercise-induced angiogenesis is primarily related to high cellular
energy requirements rather than to biomechanical changes in the
microcirculation secondary to increased blood flow. Accordingly, we
speculate that intracellular hypoxia, metabolite concentration changes,
or mechanical effects of muscle contraction might play more important
roles in the early upregulation of the expression of the VEGF gene
during exercise. In light of the present study, angiogenesis induced by
microvascular biomechanical events may require prolonged exposure to
the accompanying hemodynamic changes.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. M. C. Hogan for valuable support during the study.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-17731, HL-46910, and HL-90426 (to T. P. Gavin); and by Fondo de Investigaciones Sanitarias de la Seguridad Social Grants 97-0794 and BAE-96-5067.
Address for reprint requests: P. D. Wagner, Dept. of Medicine, Univ. of California, San Diego, La Jolla, CA 92093-0623 (E-mail: pdwagner{at}ucsd.edu).
Received 9 July 1997; accepted in final form 7 April 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adair, T. H.,
W. J. Gay,
and
J.-P. Montani.
Growth regulation of the vascular system: evidence for a metabolic hypothesis.
Am. J. Physiol.
259 (Regulatory Integrative Comp. Physiol. 28):
R393-R404,
1990
2.
Adamis, A. P.,
D. T. Shima,
M. J. Tolentino,
E. S. Gragoudas,
N. Ferrara,
J. Folkman,
P. A. D'Amore,
and
J. W. Miller.
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
Arch. Ophthalmol.
114:
66-71,
1996
3.
Aiello, L. P.,
E. A. Pierce,
E. D. Foley,
H. Takagi,
H. Chen,
L. Riddle,
N. Ferrara,
G. L. King,
and
L. E. Smith.
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Proc. Natl. Acad. Sci. USA
92:
10457-10461,
1995
4.
Anderson, P.,
and
J. Hendricksson.
Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise.
J. Physiol. (Lond.)
270:
677-690,
1977
5.
Bebout, D. E.,
M. C. Hogan,
S. C. Hempleman,
and
P. D. Wagner.
Effects of training and immobilization on
O2 and DO2 in dog gastrocnemius muscle in situ.
J. Appl. Physiol.
74:
1697-1703,
1993
6.
Borgstrom, P.,
K. J. Hillan,
P. Sriramarao,
and
N. Ferrara.
Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.
Cancer Res.
56:
4032-4039,
1996
7.
Breen, E. C.,
E. C. Johnson,
H. Wagner,
H. M. Tseng,
L. A. Sung,
and
P. D. Wagner.
Angiogenic growth factor mRNA responses in muscle to a single bout of exercise.
J. Appl. Physiol.
81:
355-361,
1997
8.
Brodal, P.,
F. Ingjer,
and
L. Hermansen.
Capillary supply of skeletal muscle fibers in untrained and endurance-trained men.
Am. J. Physiol.
232 (Heart Circ. Physiol. 1):
H705-H712,
1977
9.
Castellot, J. J.,
M. L. Addonizio,
R. Rosenberg,
and
M. J. Karnovsky.
Cultured endothelial cells produce heparin-like inhibitor of smooth muscle cell growth.
J. Cell Biol.
90:
372-379,
1981
10.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocynate-phenol chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
11.
Dawson, J. M.,
and
O. Hudlicka.
Can changes in microcirculation explain capillary growth in skeletal muscle?
Int. J. Exp. Pathol.
74:
65-71,
1993[Medline].
12.
Falanga, V.,
S. W. Qian,
D. Danielpour,
M. H. Katz,
A. B. Roberts,
and
M. B. Sporn.
Hypoxia upregulates the synthesis of TGF-
1 by human dermal fibroblasts.
J. Invest. Dermatol.
97:
634-637,
1991[Medline].
13.
Feinbert, A. P.,
and
B. Vogelstein.
A technique for radiolabeling DNA restriction endonuclease fragments to a high specific activity.
Anal. Biochem.
132:
6-13,
1983[Medline].
14.
Ferrara, N.,
K. Carver-Moore,
H. Chen,
M. Dowd,
L. Lu,
K. S. O'Shea,
L. Powell-Braxton,
K. J. Hillian,
and
M. W. Moore.
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Nature
380:
439-442,
1996[Medline].
15.
Folkman, J.,
and
A. Moscona.
Role of cell shape in growth control.
Nature
273:
345-349,
1978[Medline].
16.
Forsythe, J. A.,
B. H. Jiang,
N. V. Iyer,
F. Agani,
S. W. Leung,
R. D. Koos,
and
G. L. Semenza.
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
Mol. Cell. Biol.
16:
4604-4613,
1996[Abstract].
17.
Goto, F.,
K. Goto,
K. Weindel,
and
J. Folkman.
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
Lab. Invest.
69:
508-517,
1993[Medline].
18.
Gu, J. W.,
and
T. H. Adair.
Hypoxia-induced expression of VEGF is reversible in myocardial vascular smooth muscle cells.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H628-H633,
1997
19.
Hang, J.,
L. Kong,
J.-W. Gu,
and
T. H. Adair.
VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H1827-H1831,
1995
20.
Hudlicka, O.
Capillary growth: role of mechanical factors.
News Physiol. Sci.
16:
73-90,
1988.
21.
Hudlicka, O.,
M. Brown,
and
S. Egginton.
Angiogenesis in skeletal and cardiac muscle.
Physiol. Rev.
72:
369-417,
1992
22.
Hudlicka, O.,
M. D. Brown,
H. Walter,
J. B. Weiss,
and
A. Bate.
Factors involved in capillary growth in the heart.
Mol. Cell. Biochem.
147:
57-68,
1995[Medline].
23.
Ingber, D. E.,
J. A. Madri,
and
J. Folkman.
Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion.
In Vitro Cell. Dev. Biol.
23:
387-394,
1987[Medline].
24.
Iruela-Arispe, M.,
P. Hasselaar,
and
H. Sage.
Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
Lab. Invest.
64:
174-186,
1991[Medline].
25.
Joukov, V.,
K. Pajusola,
A. Kaipanen,
D. Chilov,
I. Lahtinen,
E. Kukk,
O. Saksela,
N. Kalkkinen,
and
K. Alitalo.
A novel vascular endothelial growth factor, VEGF-C is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
EMBO J.
15:
1751,
1996[Medline].
26.
Koo, E. W. Y.,
and
I. Gotlieb.
Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture.
Am. J. Pathol.
143:
497-503,
1989.
27.
Leung, D. W.,
G. Cachianes,
W.-J. Kuang,
D. V. Goeddel,
and
N. Ferrara.
Vascular endothelial growth factor is a secreted angiogenic mitogen.
Science
246:
1306-1309,
1989
28.
Levy, N. S.,
M. A. Goldberg,
and
A. P. Levy.
Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conversation of five hypoxia-inducible RNA-protein binding sites.
Biochim. Biophys. Acta
1352:
167-173,
1997[Medline].
29.
Li, J.,
M. A. Perrella,
J.-C. Tsai,
S.-F. Yet,
C.-M. Hsieh,
M. Yoshizumi,
C. Patterson,
W. O. Endege,
F. Zhou,
and
M.-E. Lee.
Induction of vascular endothelial growth factor gene expression by interleukin-1b in rat aortic smooth muscle cells.
J. Biol. Chem.
270:
308-312,
1995
30.
Liu, Y. X.,
S. R. Cox,
T. Morita,
and
S. Kourembanas.
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells - Identification of a 5' enhancer.
Circ. Res.
77:
638-643,
1995
31.
Merwin, J. R.,
J. M. Anderson,
O. Kocher,
and
C. M. Van Itallie.
Transforming growth factor beta1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis.
J. Cell. Physiol.
142:
117-128,
1990[Medline].
32.
Michiels, C.,
F. De Le Leener,
T. Arnould,
M. Dieu,
and
J. Rermacle.
Hypoxia stimulates human endothelial cells to release smooth cell mitogens: role of prostaglandins and bFGF.
Exp. Cell Res.
213:
43-45,
1997.
33.
Myrhage, R.,
and
O. Hudlicka.
Capillary growth in chronically stimulated adult skeletal muscle as studied by intravital microscopy and histological methods in rabbits and rats.
Microvasc. Res.
16:
73-90,
1978[Medline].
34.
Nomura, M.,
S. Yamagishi,
S. Harada,
Y. Hayashi,
T. Yamashima,
J. Yamashita,
and
H. Yamamoto.
Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes.
J. Biol. Chem.
270:
28316-28324,
1995
35.
Olofsson, B.,
K. Pajusola,
A. Kaipainen,
G. von Euler,
V. Joukov,
O. Saksela,
A. Orpana,
R. F. Pettersson,
K. Alitalo,
and
U. Eriksson.
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Proc. Natl. Acad. Sci. USA
93:
2578-2581,
1996.
36.
Qian, S. W.,
P. Konkaiah,
A. B. Roberts,
and
M. B. Sporn.
cDNA cloning by PCR of rat transforming growth factor-
1.
Nucleic Acids Res.
18:
3059,
1990
37.
Richardson, R. S.,
E. A. Noyszewski,
K. F. Kendrick,
J. S. Leigh,
and
P. D. Wagner.
Myoglobin O2 desaturation during exercise: evidence of limited O2 transport.
J. Clin. Invest.
96:
1916-1926,
1995.
38.
Risau, W.,
and
I. Flamme.
Vasculogenesis.
Ann. Rev. Cell Dev. Biol.
11:
79-91,
1995.
39.
Shweiki, D.,
A. Itin,
D. Soffer,
and
E. Keshet.
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
Nature
359:
843-845,
1992[Medline].
40.
Tillmans, H.,
M. Steinhausen,
H. Leinberger,
H. Thederan,
and
W. Kübler.
The effect of coronary vasodilators on the microcirculation of the ventricular myocardium.
In: Microcirculation of the Heart, edited by H. Tillmans,
W. Kübler,
and H. Zebe. Berlin: Springer-Verlag, 1982, p. 305-312.
41.
Yuan, F.,
Y. Chen,
M. Dellian,
N. Safabakhsh,
N. Ferrara,
and
R. K. Jain.
Time-dependent vascular regression and permeability in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Proc. Natl. Acad. Sci. USA
93:
14765-14770,
1996
This article has been cited by other articles:
![]() |
N. M. Siafakas and I. Mitrouska The immune response to resistive breathing Eur. Respir. J., June 1, 2005; 25(6): 1128 - 1129. [Full Text] [PDF] |
||||
![]() |
W. L. Murfee, L. A. Hammett, C. Evans, L. Xie, M. Squire, C. Rubin, S. Judex, and T. C. Skalak High-frequency, low-magnitude vibrations suppress the number of blood vessels per muscle fiber in mouse soleus muscle J Appl Physiol, June 1, 2005; 98(6): 2376 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Prior, H. T. Yang, and R. L. Terjung What makes vessels grow with exercise training? J Appl Physiol, September 1, 2004; 97(3): 1119 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tang, E. C. Breen, H.-P. Gerber, N. M. A. Ferrara, and P. D. Wagner Capillary regression in vascular endothelial growth factor-deficient skeletal muscle Physiol Genomics, June 17, 2004; 18(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J G Birot, N. Koulmann, A. Peinnequin, and X. A Bigard Exercise-Induced Expression of Vascular Endothelial Growth Factor mRNA in Rat Skeletal Muscle is Dependent on Fibre Type J. Physiol., October 1, 2003; 552(1): 213 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Olfert, E. C. Breen, O. Mathieu-Costello, and P. D. Wagner Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia J Appl Physiol, September 1, 2001; 91(3): 1176 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Amaral, P. E. Papanek, and A. S. Greene Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1163 - H1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Wagner, F. Masanes, H. Wagner, E. Sala, O. Miro, J. M. Campistol, R. M. Marrades, J. Casademont, V. Torregrosa, and J. Roca Muscle angiogenic growth factor gene responses to exercise in chronic renal failure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R539 - R546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vogt, A. Puntschart, J. Geiser, C. Zuleger, R. Billeter, and H. Hoppeler Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions J Appl Physiol, July 1, 2001; 91(1): 173 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M. Siafakas, M. Jordan, H. Wagner, E.C. Breen, H. Benoit, and P.D. Wagner Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Eur. Respir. J., April 1, 2001; 17(4): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Gavin and P. D. Wagner Effect of short-term exercise training on angiogenic growth factor gene responses in rats J Appl Physiol, April 1, 2001; 90(4): 1219 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Gavin, D. A. Spector, H. Wagner, E. C. Breen, and P. D. Wagner Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise J Appl Physiol, May 1, 2000; 88(5): 1690 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Richardson, H. Wagner, S. R. D. Mudaliar, R. Henry, E. A. Noyszewski, and P. D. Wagner Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2247 - H2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Hepple, T. L. Babits, M. J. Plyley, and J. M. Goodman Dissociation of peak vascular conductance and VO2 max among highly trained athletes J Appl Physiol, October 1, 1999; 87(4): 1368 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Benoit, M. Jordan, H. Wagner, and P. D. Wagner Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression J Appl Physiol, May 1, 1999; 86(5): 1513 - 1518. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |